Skip to main content
. 2015 Jul-Sep;20(3):139–142. doi: 10.4103/0971-9261.159029

Figure 1.

Figure 1

(a) Graphical representation of the levels of nitric oxide (NO) (μmol/l) in patients with neonatal cholestasis (Groups I and II taken together) as compared to the control group. (b) Graphical representation of the levels of NO (μmol/l) in patients with extrahepatic biliary atresia (Group I), neonatal hepatitis (Group II) and in the control group